RNA delivery to the corneal endothelium using charge-altering releasable transporters
Science Advances · 21.08.2026 · 12 (34)
DOI: 10.1126/sciadv.ady8161 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 21.08.2026. Verfasst von Sean K Wang und 19 weiteren Autor:innen. Beteiligte Einrichtung: Center for Personal Dynamic Regulomes, Stanford University, Stanford, CA, USA. Hauptthemen laut MEDLINE: Endothelium, Corneal, Gene Transfer Techniques, RNA. Die Arbeit nennt 88 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NEI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
RNA therapies hold tremendous promise for treating genetic eye diseases. However, their development is limited by the lack of non-viral delivery platforms that can target specific ocular cell types. Here, we describe a charge-altering releasable transporter (CART) that delivers RNA selectively to the corneal endothelium, a non-regenerative cell layer whose dysfunction underlies several blinding conditions. We characterize the safety of CART-RNA nanoparticles in mice and show that they facilitate delivery of diverse RNA cargoes to the corneal endothelium, including circular RNA and CRISPR/Cas9. We verify that these nanoparticles can be redosed and apply them to achieve corneal gene editing. We further demonstrate CART transfection of corneal endothelial cells from a human donor in vitro and in a non-human primate in vivo, supporting the feasibility of clinical translation. Our findings establish CARTs as a platform for non-viral gene delivery to the eye, with the potential to treat corneal dystrophies and other vision disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Personal Dynamic Regulomes, Stanford University, Stanford, CA, USA.
- Department of Ophthalmology, Stanford University School of Medicine, Stanford, CA, USA.
- Department of Chemistry, Stanford University, Stanford, CA, USA.
- Virscio, Inc., New Haven, CT, USA.
- RNA Medicine Program, Stanford University, Stanford, CA, USA.
- College of Pharmacy, The Catholic University of Korea, Bucheon, Republic of Korea.
ORCID-Profile: Sean K Wang, Sahil H Shah, Quincy A Edwards, Richard Bouffard, Elizabeth S Hines, Matthew S Lawrence, Euisun Song, Laura Amaya, Nae-Won Kang, William J Greenleaf, Robert M Waymouth, Sui Wang, Paul A Wender, Howard Y Chang
Förderung
- NCI NIH HHS
- NEI NIH HHS
- National Institutes of Health
- Howard Hughes Medical Institute
- KNIGHTS TEMPLAR EYE FOUNDATION
- Stanford RNA Medicine Program
- Stanford Center for Molecular Analysis and Design
Zitieren
APA
Wang, S. K., Li, Z., Shah, S. H., Edwards, Q. A., Bouffard, R., Hines, E. S., Imventarza, J. A., Korte, S., Lawrence, M. S., Song, E., Helmy, E., Amaya, L., Kang, N. W., Myung, D., Tsai, M. C., Greenleaf, W. J., Waymouth, R. M., Wang, S., Wender, P. A., & Chang, H. Y. (2026). RNA delivery to the corneal endothelium using charge-altering releasable transporters. Science Advances, 12(34). https://doi.org/10.1126/sciadv.ady8161
Vancouver
Wang SK, Li Z, Shah SH, Edwards QA, Bouffard R, Hines ES, et al. RNA delivery to the corneal endothelium using charge-altering releasable transporters. Science Advances. 2026;12(34). doi:10.1126/sciadv.ady8161
BibTeX
@article{Wang2026,
author = {Wang, Sean K and Li, Zhijian and Shah, Sahil H and Edwards, Quincy A and Bouffard, Richard and Hines, Elizabeth S and Imventarza, Joel A and Korte, Sven and Lawrence, Matthew S and Song, Euisun and Helmy, Ekram and Amaya, Laura and Kang, Nae-Won and Myung, David and Tsai, Miao-Chih and Greenleaf, William J and Waymouth, Robert M and Wang, Sui and Wender, Paul A and Chang, Howard Y},
title = {RNA delivery to the corneal endothelium using charge-altering releasable transporters},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {34},
doi = {10.1126/sciadv.ady8161}
}
EUVIMED